Product Images Docetaxel
View Photos of Packaging, Labels & Appearance
- Structural Formula - doc08 0000 01 v2
- Figure 1 - doc08 0000 02 v2
- Figure 2 - doc08 0000 03 v2
- Figure 3 - doc08 0000 04
- Figure 4 - doc08 0000 05
- Figure 5 - doc08 0000 06 v3
- Figure 6 - doc08 0000 07 v2
- Figure 7 - doc08 0000 08 v2
- Figure 8 - doc08 0000 09 v3
- Figure 9 - doc08 0000 10 v2
- Figure 10 - doc08 0000 11 v2
- PRINCIPAL DISPLAY PANEL – Docetaxel Injection, USP, 20 mg per mL Vial Label - doc08 0000 12 v4
- PRINCIPAL DISPLAY PANEL – Docetaxel Injection, USP, 20 mg per mL Carton - doc08 0000 13 v4
- PRINCIPAL DISPLAY PANEL – Docetaxel Injection, USP, 80 mg per 4 mL Vial Label - doc08 0000 14 v4
- PRINCIPAL DISPLAY PANEL – Docetaxel Injection, USP, 80 mg per 4 mL Carton - doc08 0000 15 v4
Product Label Images
The following 15 images provide visual information about the product associated with Docetaxel NDC 71288-152 by Meitheal Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - doc08 0000 02 v2

This text appears to show a chart representing the probability of disease-free survival over time in months. The values on the x-axis range from 0 to 66 months, while the y-axis shows the probability of disease-free survival in percentage.*
Figure 3 - doc08 0000 04

This text provides information about cumulative family overall survival data, with emphasis on the log-rank test result of p=0.010. The graph appears to show survival time in months.*
Figure 9 - doc08 0000 10 v2

The text describes survival probabilities at different time intervals in months. The survival probabilities are given in percentages at various time points ranging from 18 to 72 months.*
PRINCIPAL DISPLAY PANEL – Docetaxel Injection, USP, 20 mg per mL Vial Label - doc08 0000 12 v4

This text contains information about a cytotoxic agent called docetaxel USP with a concentration of 20 mg per mL. It is intended for intravenous use only and comes in a 1 mL single-dose vial. The product is manufactured by Meitheal Pharmaceuticals and should be added to infusion solutions as per the package insert instructions. The manufacturer's address is provided as 8700 W Bryn Mawr, Ste 600S, Chicago, IL 60631 (USA). Please refer to the lot number on the packaging for tracking purposes.*
PRINCIPAL DISPLAY PANEL – Docetaxel Injection, USP, 20 mg per mL Carton - doc08 0000 13 v4

This text provides detailed information about Docetaxel Bronty, a cytotoxic agent used for intravenous injection in medical settings. It contains important instructions for healthcare professionals, such as the dosage (20 mg per mL), the route of administration (intravenous use only), and the proper handling of the single-dose vials. The text emphasizes caution due to the cytotoxic nature of the drug, and it reminds to discard any unused portion properly. Reading and understanding this information is essential for safe administration and disposal of the medication.*
PRINCIPAL DISPLAY PANEL – Docetaxel Injection, USP, 80 mg per 4 mL Vial Label - doc08 0000 14 v4

This is a description of a medication called Docetaxel, which is an injection containing 80 mg per 4 mL (20 mg per mL) for intravenous use only. It is a cytotoxic agent and should be added to an infusion solution. The medication is stored between 2° and 25°C, protected from light. The manufacturer is Meitheal Pharmaceuticals based in Chicago, IL, USA. A caution is given to discard any unused portion of the 4 mL single-dose vial.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.